Identifying High-Risk Groups Certain individuals are more likely to develop blood clots when using semaglutide
If you're taking insulin, sulfonylureas, or other diabetes medications alongside GLP-1 therapy, you're at higher risk for hypoglycemia
The FDA-approved dosing schedule for Wegovy is: Week 1-4: 0.25 mg dose once weekly for the first 4 weeks (starting dose)/ Week 5-8: 0.5 mg dose once weekly Week 9-12: 1 mg once weekly, if needed Week 13-16: 1.7 mg once weekly, if needed Week 17 and beyond: 1.7 mg or 2.4 mg (maximum dose) The initial dose of Ozempic is 0.25 mg, which is injected once weekly for the first 4 weeks
Leffetto complessivo un miglioramento del compenso glicemico e, secondariamente, della sensibilit insulinica
Vomiting is a more serious sign
These statements have not been evaluated by Health Canada or the FDA